Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Other Working Capital Changes: 2020-2024

Historic Other Working Capital Changes for Therapeutics (RAPT) over the last 5 years, with Dec 2024 value amounting to -$720,000.

  • Therapeutics' Other Working Capital Changes fell 3.45% to -$720,000 in Q4 2024 from the same period last year, while for Dec 2024 it was -$2.9 million, marking a year-over-year decrease of 5.47%. This contributed to the annual value of -$2.9 million for FY2024, which is 5.47% down from last year.
  • Latest data reveals that Therapeutics reported Other Working Capital Changes of -$720,000 as of Q4 2024, which was down 1.12% from -$712,000 recorded in Q3 2024.
  • In the past 5 years, Therapeutics' Other Working Capital Changes ranged from a high of $5.1 million in Q1 2020 and a low of -$1.5 million during Q3 2020.
  • Over the past 3 years, Therapeutics' median Other Working Capital Changes value was -$692,500 (recorded in 2023), while the average stood at -$638,250.
  • As far as peak fluctuations go, Therapeutics' Other Working Capital Changes soared by 94.21% in 2022, and later slumped by 1,128.57% in 2023.
  • Therapeutics' Other Working Capital Changes (Quarterly) stood at -$1.3 million in 2020, then spiked by 41.62% to -$756,000 in 2021, then spiked by 32.01% to -$514,000 in 2022, then tumbled by 35.41% to -$696,000 in 2023, then fell by 3.45% to -$720,000 in 2024.
  • Its last three reported values are -$720,000 in Q4 2024, -$712,000 for Q3 2024, and -$712,000 during Q2 2024.